Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Human CD21 low CD86 pos B Cells Are Potent Antigen Presenting Cells, Which Are Expanded in Inflammatory Conditions

Alexander Shimabukuro-Vornhagen, MD, María Alejandra García-Márquez, PhD, Rieke N. Fischer, Juliane Iltgen-Breburda, Anne Fiedler, Kerstin Wennhold, PhD, Gunter Rappl, Hinrich Abken, Pia Hartmann, Clara Lehmann, Thomas Koslowsky, Marco Herling, MD, Dirk Beutner, Dominik Wolf, MD, Gerd Fätkenheuer, Andrea Rubbert-Roth, Michael Hallek, MD, Sebastian Theurich, Michael von Bergwelt-Baildon, Prof. Dr. Dr.

Blood (2015) 126 (23): 3432.

https://doi.org/10.1182/blood.V126.23.3432.3432

Published: 2015

Journal Articles

Tumorantigen-Specific CD40B Cells: Combining Enhanced Antigen-Presentation and Antibody-Secretion for Tumor Targeting

Kerstin Wennhold, PhD, Martin Thelen, Maria gracia Marquez, Christof Scheid, MD PhD, Alexander Shimabukuro-Vornhagen, MD, Michael von Bergwelt-Baildon, Prof. Dr. Dr.

Blood (2015) 126 (23): 1030.

https://doi.org/10.1182/blood.V126.23.1030.1030

Published: 2015

Journal Articles

In Vitro and in Vivo Imaging of Initial T-B Cell Interactions in the Setting of B Cell-Based Cancer Immunotherapy

Kerstin Wennhold, Nela Klein-Gonzalez, PhD, Michael von Bergwelt-Baildon, MD PhD, Alexander Shimabukuro-Vornhagen, MD

Blood (2014) 124 (21): 2740.

https://doi.org/10.1182/blood.V124.21.2740.2740

Published: 2014

Journal Articles

The CD21 low B Cell Population Is Composed of an Anergic and an Immunostimulatory Germinal Center-like B Cell Subset

Alexander Shimabukuro-Vornhagen, MD, María García Márquez, Rieke Fischer, MD, Kerstin Wennhold, Juliane Iltgen, Sebastian Theurich, MD, Michael S. von Bergwelt-Baildon, MD PhD

Blood (2014) 124 (21): 1425.

https://doi.org/10.1182/blood.V124.21.1425.1425

Published: 2014

Journal Articles

CD30-Targeted Therapy with Brentuximab Vedotin Combined with Donor Lymphocyte Infusions Induce Sustained Clinical Remissions and Tumor Specific Immunity in a Series of Patients with Relapsed Hodgkin Lymphoma After Allogeneic Stem Cell Transplantation

Sebastian Theurich, MD, Joke Malcher, Kerstin Wennhold, Alexander Shimabukuro-Vornhagen, MD, Jens M. Chemnitz, MD, Holtick Udo, MD, Anke Krause, MD, Carsten Kobe, MD, Deniz Kahraman, MD, Chakupurakal Geothy, Andreas Engert, MD PhD, Scheid Christof, MD, Michael Hallek, MD PhD, Michael von Bergwelt-Baildon, MD, PhD

Blood (2012) 120 (21): 4213.

https://doi.org/10.1182/blood.V120.21.4213.4213

Published: 2012

NARROW

Human CD21 low CD86 pos B Cells Are Potent Antigen Presenting Cells, Which Are Expanded in Inflammatory Conditions

Tumorantigen-Specific CD40B Cells: Combining Enhanced Antigen-Presentation and Antibody-Secretion for Tumor Targeting

In Vitro and in Vivo Imaging of Initial T-B Cell Interactions in the Setting of B Cell-Based Cancer Immunotherapy

The CD21 low B Cell Population Is Composed of an Anergic and an Immunostimulatory Germinal Center-like B Cell Subset

CD30-Targeted Therapy with Brentuximab Vedotin Combined with Donor Lymphocyte Infusions Induce Sustained Clinical Remissions and Tumor Specific Immunity in a Series of Patients with Relapsed Hodgkin Lymphoma After Allogeneic Stem Cell Transplantation

Email alerts

ASH Publications

American Society of Hematology

Human CD21 low CD86 pos B Cells Are Potent Antigen Presenting Cells, Which Are Expanded in Inflammatory Conditions

Tumorantigen-Specific CD40B Cells: Combining Enhanced Antigen-Presentation and Antibody-Secretion for Tumor Targeting

In Vitro and in Vivo Imaging of Initial T-B Cell Interactions in the Setting of B Cell-Based Cancer Immunotherapy

The CD21 low B Cell Population Is Composed of an Anergic and an Immunostimulatory Germinal Center-like B Cell Subset

CD30-Targeted Therapy with Brentuximab Vedotin Combined with Donor Lymphocyte Infusions Induce Sustained Clinical Remissions and Tumor Specific Immunity in a Series of Patients with Relapsed Hodgkin Lymphoma After Allogeneic Stem Cell Transplantation

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only